A Study for the Collection of Clinical Data for Stroke Patients and Healthy Subjects
NCT05908994, Unknown, Bundang CHA Hospital
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | A Study for the Collection of Clinical Data for Stroke Patients and Healthy Subjects | ClinicalTrials.gov |
| NCT number | NCT05908994 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Enrollment | 100 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Bundang CHA Hospital | ClinicalTrials.gov |
| Conditions | Stroke, Health Behavior | ClinicalTrials.gov |
| Interventions | Examination | ClinicalTrials.gov |
| First posted | 2023-06-18 | ClinicalTrials.gov |
| Last updated | 2023-06-18 | ClinicalTrials.gov |
Registered outcomes 31
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Changes in motion analysis | Change from baseline to 6 months, 12 months, 18 months and 24 months | Motion analysis is a process of measuring and evaluating gait function in kinetic and kinematic parameters | ClinicalTrials.gov |
| Secondary | Changes in X-ray radiography | Change from baseline to 6 months, 12 months, 18 months and 24 months | X-ray radiography is a process of measuring and detecting the structural changes of bones including thorax, whole spine, lower extremity | ClinicalTrials.gov |
| Secondary | Changes in computed tomogrphy (CT) | Change from baseline to 6 months, 12 months, 18 months and 24 months | CT scan is a process of measuring and detecting the structural changes of spine | ClinicalTrials.gov |
| Secondary | Changes in magnetic resonanace imaging (MRI) | Change from baseline to 6 months, 12 months, 18 months and 24 months | MRI scan is a process of measuring changes of diffusion tensor tractography | ClinicalTrials.gov |
| Secondary | Changes in manual muscle test (MMT) | Change from baseline to 6 months, 12 months, 18 months and 24 months | MMT is a process of the evaluating the function and strength of individual muscles and muscle groups based on the effective performance of a movement in relation to the forces of gravity and manual resistance in score | ClinicalTrials.gov |
| Secondary | Changes in motricity index (MI) | Change from baseline to 6 months, 12 months, 18 months and 24 months | MI is a process of the evaluating the function and strength of upper, lower extremities and trunk in score | ClinicalTrials.gov |
| Secondary | Changes in range of motion (ROM) | Change from baseline to 6 months, 12 months, 18 months and 24 months | ROM testing is a measurement of movement around a specific joint of body part in angle | ClinicalTrials.gov |
| Secondary | Changes in berg balance scale (BBS) | Change from baseline to 6 months, 12 months, 18 months and 24 months | BBS is a measurement of balancing function. A five-point ordinal scale, ranging from 0-4. "0" indicates the lowest level of function and "4" the highest level of function. Total score = 56 | ClinicalTrials.gov |
| Secondary | Changes in motor assessment scale (MAS) | Change from baseline to 6 months, 12 months, 18 months and 24 months | MAS is a measurement of performance-based scale for assessing everyday motor function. The MAS is comprised of 8 items corresponding to 8 areas of motor function. All items are assessed using a 7-point scale from 0-6. | ClinicalTrials.gov |
| Secondary | Changes in trunk impairment scale (TIS) | Change from baseline to 6 months, 12 months, 18 months and 24 months | MAS is a measurement of static and dynamic sitting balance and trunck coordination in a sitting position. For each item, a 2-, 3- or 4- point ordinal scale is used. The total score for TIS ranges between 0 for a minimal performance to 23 for a perfect performance. | ClinicalTrials.gov |
| Secondary | Changes in functional ambulatory category (FAC) | Change from baseline to 6 months, 12 months, 18 months and 24 months | FAC is a measurement of a functional walking test that evaluates ambulation ability. This 6-point scale assesses ambulation status by determining how much human support the patient requires when walking, regardless of whether or not they use personal assistive device. | ClinicalTrials.gov |
| Secondary | Changes in Gait rite | Change from baseline to 6 months, 12 months, 18 months and 24 months | Gait rite is a measurement of a temporal and spatial parameters during gait | ClinicalTrials.gov |
| Secondary | Changes in time up and go test (TUG) | Change from baseline to 6 months, 12 months, 18 months and 24 months | TUG is a measurement of a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down. 11-20 seconds are within normal limits for frail elderly and disables patients, and greater than 20 seconds means the person needs assistance outside and indicates further examintaiton and intervention. A score of 30 seconds or more suggests that the person may be prone to falls. | ClinicalTrials.gov |
| Secondary | Changes in Fugl-meyer assessement (FMA) | Change from baseline to 6 months, 12 months, 18 months and 24 months | FMA is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sesation and joint functioning in patients with post-stroke hemiplegia. It is applied clinically and in research determine disease severity, describe motor recovery, and to plan and assess treatment. | ClinicalTrials.gov |
| Secondary | Changes in action research arm test (ARAT) | Change from baseline to 6 months, 12 months, 18 months and 24 months | ARAT is a 19 item observational measurement to assess upper extremity performance (coordination, dexterity and functioning). Items comprising ARAT are categorized into four subscales (grasp, grip, pinch and gross movement). Task performance is rated on a 4-point scale, ranging from 0 (no movement) to 3 (movement performend normally) | ClinicalTrials.gov |
| Secondary | Changes in fuctional independence meausure (FIM) | Change from baseline to 6 months, 12 months, 18 months and 24 months | FIM is a measurment to evaluate the funciontional status. FIS is an 18-item including functional capability in six areas of self-care, continence, mobility, transfers, communication and cognition. Each of the 18 items are graded on a scale of 1-7, based on the level of independence in that item | ClinicalTrials.gov |
| Secondary | Changes in modified barthel-index (MBI) | Change from baseline to 6 months, 12 months, 18 months and 24 months | MBI is a measurement of degree of independence of a patient from any assistance. It covers 10 domains of daily activities: bowel and bladder control, grooming, toilet use, feeding, trasnfers, walking, dressing, climbing stairs and bating | ClinicalTrials.gov |
| Secondary | Changes in national institute of health care stroke scale (NIHSS) | Change from baseline to 6 months, 12 months, 18 months and 24 months | NIHSS is a measurement for assessing the severity of stroke patients. The scale is made up of 11 different elements that evaluate specific ability. The score for each ability is a number between 0 and 4, 0 being normal functioning and 4 being completely impaired. 42 is the highest score possible, the higher the score, the more impaired a stroke patient is. | ClinicalTrials.gov |
| Secondary | Changes in stroke specific quality of life (SS-QoL) | Change from baseline to 6 months, 12 months, 18 months and 24 months | SS-QoL is an instrument designed to measure th quality of life (QOL) of stroke population and is intended to identify common areas that affect health-related QoL. The assessment is composed of 49 items within 12 domains that include such items as energy, family roles, mobility, and self-care. The SS-QoL has a score range of 49 to 245 with higher scores indicating better HR-QoL. | ClinicalTrials.gov |
| Secondary | Changes in Korean version of Montreal cognitive assessment (K-MoCA) | Change from baseline to 6 months, 12 months, 18 months and 24 months | K-MoCA is a measurement to evaluate the memory loss or other symptoms of cognitive decline. It contains 30 questions and taskes around to 12 minutes to complete. Scores range from 0 to 30. A score of 26 and higher is considered normal. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 41327370 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Complex Figure Copy and Recall | Secondary outcome | ConductCognition |
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)